Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20509

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

December 14, 2017

Date of Report

(Date of earliest event reported)

 

FUTURE HEALTHCARE OF AMERICA

(Exact name of registrant as specified in its charter)

 

WYOMING	000-54917	45-5547692
(State or other jurisdiction of incorporation or organization)	Commission File Number	(I.R.S. Employer Identification No.)

 

5001 Baum Boulevard, Suite 770

Pittsburgh, Pennsylvania 15213

(Address of principal executive offices)

 

[phone]

Registrant's telephone number

 

N/A

Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item	8.01 Other Events.

 

Effective as of December 14, 2017, the Board of Directors of Future Healthcare of America, a Wyoming corporation (the “Company”), unanimously resolved to reduce the exercise price of the Company’s outstanding Variable Rate Senior Secured Convertible Debenture dated September 9, 2013, in the principal amount of $1,010,000, from $0.25 per share to $0.10 per share.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

FUTURE HEALTHCARE OF AMERICA,

a Wyoming corporation

 

 

Dated: December 20, 2017

By /s/ Christopher J. Spencer Christopher J. Spencer, Chief Executive Officer, President and Director